Vaccines are the focus of the global fight against COVID-19, but a flurry of therapeutic breakthroughs and fights over a limited supply of antibody drugs are returning treatments back to the spotlight. Merck said this month it will ask the Food and Drug Administration to authorize a course of pills ...
Business daily
Merkez mahallesi mutlu han sokak no:17/2 Bartın/Sakarya
info@businessdaily.com.tr